Olmevas HZ is a combination antihypertensive medication used for the treatment of high blood pressure (hypertension). It combines the blood pressure-lowering effects of Olmesartan, an angiotensin II receptor blocker (ARB), and Hydrochlorothiazide, a thiazide diuretic, to provide effective blood pressure control.
Key Features:
- Helps lower elevated blood pressure
- Reduces the risk of cardiovascular complications associated with hypertension
- Combines dual mechanisms for enhanced blood pressure control
- Once-daily dosing for convenient administration
Pharmacology
Olmesartan Medoxomil
- Blocks the action of angiotensin II at AT1 receptors
- Relaxes blood vessels and lowers blood pressure
- Reduces aldosterone secretion
Hydrochlorothiazide
- Increases excretion of sodium and water through the kidneys
- Reduces blood volume, helping lower blood pressure
- Works synergistically with Olmesartan
Dosage & Administration
- Usual starting dose: 20 mg/12.5 mg once daily
- Dose may be adjusted according to blood pressure response
- Maximum recommended dose: 40 mg/25 mg once daily
- Dose titration is generally done at intervals of 2-4 weeks
Side Effects
Common side effects may include:
- Headache
- Dizziness
- Nausea
- Hyperuricemia
- Upper respiratory tract infection
- Urinary tract infection
- Abdominal pain
- Diarrhea
- Dyspepsia
- Peripheral edema
Contraindications
- Hypersensitivity to Olmesartan, Hydrochlorothiazide, or any component of the formulation
- Anuria
- Hypersensitivity to sulfonamide-derived drugs
Precautions
- Regular monitoring of serum electrolytes is recommended
- Use cautiously in patients with impaired kidney function
- Hyperuricemia may occur during therapy
- Elderly patients may require careful dose selection